By Dr Dustin E Bosch (BellBrook Labs)2024-01-05T08:02:51
Naegleria fowleri infections are rare but almost invariably fatal, with pathologic sequelae spawning its common label as ‘the brain-eating amoeba’. Researchers identified two unique proteins within N. fowleri – self-activating guanine nucleotide-hydrolysing proteins (G proteins) – that present novel targets for drug discovery. This article summarises their work to date, ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-10-22T14:00:00Z
Sponsored by Wuxi Biologics
2025-10-08T14:00:00Z
Sponsored by Eurofins Discovery
2025-07-30T08:00:00Z
Sponsored by Wuxi Biologics
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud